van Houte Hans
Known title: Chief Financial OfficerCIK: 0001817217
Associated companies
Transaction History
| NRIX | ▼ Sell | Open Market | 1,794 | $43K | 8/4/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,967 | $73K | 8/4/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,572 | $0 | 7/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,845 | $67K | 7/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 13,473 | $223K | 5/5/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 582 | $10K | 5/5/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,388 | $40K | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 4/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,887 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2026 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,859 | $0 | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,588 | $59K | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 73 | $1K | 1/30/2026 | View on chart |
| NRIX | ▼ Sell | Open Market | 6,284 | $79K | 11/3/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 10/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,130 | $40K | 10/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,402 | $60K | 8/1/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 4,304 | $52K | 7/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,858 | $0 | 7/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 6,198 | $70K | 5/2/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 4/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,438 | $28K | 4/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 700 | $11K | 3/3/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 5,125 | $74K | 3/3/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2025 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 254 | $5K | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,557 | $51K | 1/30/2025 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,546 | $86K | 11/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 10/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,368 | $58K | 10/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 20,000 | $504K | 8/26/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,377 | $72K | 8/1/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 100 | $2K | 8/1/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 3,750 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 7/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 2,490 | $51K | 7/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 20,000 | $400K | 6/20/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,499 | $45K | 5/2/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 4/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 4/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,387 | $17K | 4/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 6,812 | $68K | 2/16/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 1/30/2024 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 1/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,671 | $13K | 1/30/2024 | View on chart |
| NRIX | ▼ Sell | Open Market | 3,541 | $35K | 12/20/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 10,906 | $109K | 12/19/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,080 | $6K | 10/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 10/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 10/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 1,245 | $12K | 7/31/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 7/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,000 | $0 | 7/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 721 | $7K | 5/1/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 4/30/2023 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 924 | $11K | 1/30/2023 | View on chart |
| NRIX | ▼ Sell | Open Market | 739 | $10K | 10/31/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 10/30/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 752 | $12K | 8/1/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 7/30/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 68,333 | $57K | 5/31/2022 | View on chart |
| NRIX | ▼ Sell | Open Market | 697 | $8K | 5/2/2022 | View on chart |
| NRIX | ▲ Buy | Option Exercise | 2,886 | $0 | 4/30/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension
Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.
Nurix Advances Bexobrutideg Studies and Secures $10M Gilead Extension. Nurix has enrolled its first patient in a Phase 1b/2 study of Bexobrutideg for chronic lymphocytic leukemia, and a second enrollment began for a Bexobrutideg plus Venetoclax combination under a Roche partnership. The company also received a second research term extension for its oncology program with Gilead Sciences and secured $10 million from Gilead as part of the extended drug‑discovery collaboration. These developments show ongoing progress in Nurix’s pipeline and continued partnership support.